Coronavirus: Spotlight on the Supply Chain
Industry offers insight into vitamin C supply chain
The coronavirus highlights how much the world depends on China for key ingredients.
Archives for April 2, 2020
New evidence emerges from Amarin’s EPA drug trial; company to appeal ruling invalidating patent
A ruling on an Amarin patent and a new paper looking through data of a clinical trial on the company’s EPA-based drug have potential implications for the omega-3s dietary supplements sector.
FDA sends warning letter to CBD firm over coronavirus claims
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
Coronavirus: Spotlight on the Supply Chain
India lockdown affecting ashwagandha supply, but US inventories remain strong
Supplies of the Ayurveda’s flagship herb Ashwagandha from India are tightening as the country goes on lockdown because of the novel coronavirus, but two leading US suppliers tell NutraIngredients-USA that their domestic inventories remain robust.
CRN UK highlights why essential nutrients have never been more essential
The ongoing threat of coronavirus could increase the potential for deficiencies in key micronutrients supporting the immune system, according to The Council for Responsible Nutrition UK (CRN UK).
Soil nutrition: NZ start-up to explore fulvic acid use for sports nutrition, gut, and immune health
New Zealand start-up NZ Fulvic is studying the use of fulvic acid, a nutrient from soil extract, in providing sports nutrition, gut, and immune health benefits.